A key lawmaker and women’s health advocates applauded FDA’s Thursday (Dec. 16) decision to loosen restrictions on the abortion pill, mifepristone, so that it can be delivered to patients through the mail and dispensed by certain pharmacies. The decision was expected by women’s health advocates, who said loosening up at least some of the prescribing restrictions on mifepristone would allow for the drug to be accessed remotely and possibly even help preserve some access to medication abortion care as an...